Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall sereventSerevent is the brand name of a drug created by GlaxoSmithKline for the treatment of asthma. A recent study of Serevent and another Glaxo asthma product, Advair, found that both drugs can trigger fatal attacks in some patients. A safety monitoring board shut down the Serevent study once the heightened risk of death was discovered. Since then, the FDA has forced Glaxo to place a black box warning on Serevent and Advair, disclosing the significant risk of death on the packaging and in advertisements. As of December 2003, no such warning existed on product packaging or marketing material for Serevent.
Serevent is an aerosol spray used twice daily to open the bronchial airways, allowing asthma patients to breathe more easily. It is a very popular asthma medication, and is widely used, making the lack of a visible warning of potentially lethal side effects for users of Serevent all the more disturbing. Although the Glaxo study was cut short, the risks associated with Serevent can be seen in the data that was collected showed that three times the number of asthmatics using Serevent or Advair died of asthma than asthma patients who used alternate medications or a placebo. The risk is also increased for patients using Serevent who do not use a companion medication to control inflammation. African-Americans using Serevent are at a greatly increased risk of lethal side effects compared to other races, although researchers are still uncertain as to why African-Americans are disproportionately affected.
If you or a loved one is taking Serevent, you should consult a physician with any concerns you may have regarding side effects and complications. Patients using Serevent should not discontinue the use of this drug without first consulting a doctor. Persons who believe they are suffering from side effects of Serevent or Advair should contact an attorney who has experience representing Serevent patients to learn more about their legal rights and potential courses of action. Patients injured by their use of Serevent could be entitled to financial restitution for lost wages, health costs, pain and suffering, etc.
Two of the most popular asthma medications, Advair and Serevent, will carry the strongest warning label alerting consumers of the heightened risk of death associated with an ingredient found in these drugs.
The new “black box” warning cautions...
An FDA advisory committee unanimously recommended three asthma medications – Serevent, Advair and Foradil – remain on the market, but urged more research to determine whether the medications might worsen asthma in certain patients.
The pane...
Medwatch- Serevent safety alert letter from GlaxoSmithKline to health care professionals.